Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
RECAP 7/29 Unusual Puts: $CAVA Sep 65 P $PDD Aug01 115 P $PARA Aug 12 P $CRWV Aug 60 P $NFE Dec 3 P $HOOD Sep 95 P $CSX Sep 35 P $NVO Mar 50 P $OXY Sep 40 P $OXY Dec 35 p $NVDA Dec 146 P $SBUX Sep 85 P $AAL Oct 11 P $KVUE Sep 22 P Live Breaking trading news
RECAP 7/29 Unusual Calls: $SMCI Aug08 60/70 C Spd $SLS Jan 2 C $SBET Aug08 58 C $HPP Sep 2.5 C $NKTX Nov 2.5 C $BTBT Jan 5 C $MARA Jan 40 C $KVUE Aug08 22.5 C $GLW Nov 65 C $OPEN Aug 3 C $GOOG Dec 200 C $MGM Aug 38.5 C $CCL Sep 31 C $FCX Aug08 46 C Live Breaking trading news
RECAP 7/29 +Pos Comments: $FULC + HC Wainwright RECAP 7/29 -Neg Comments: $UTHR $LQDA - Bleecker St $NSC - RBC $NEO - William Blair $META - Needham $NEOG - William Blair $UPS - BofA Live Breaking trading news https://t.co/yChRCoaR8v
Fulcrum Therapeutics (ticker: FULC) reported its second-quarter results alongside promising Phase 1b clinical trial data for a pill aimed at treating sickle cell disease. While the study results indicate potential benefits, experts have noted that the drug's effect was modest and emphasized the need for additional data to confirm patient benefits. The news led to a 14.2% decline in Fulcrum's stock price in pre-market trading. In the broader market, unusual options activity was observed, including increased call option volumes for companies such as XLB, UPXI, DOC, GNW, IOT, OPEN, COUR, SFIX, and HNRG, and rising put option volumes for OPEN, SLG, XLB, HOG, GPRO, JCI, EWC, CHTR, IEP, AR, and TECK. Other companies receiving analyst commentary included CSX, BNSF, CNI, CYBR, PANW, OKTA, UTHR, LQDA, NSC, NEO, META, NEOG, and UPS.
